comparemela.com

Latest Breaking News On - Justin kim oppenheimer company analyst - Page 1 : comparemela.com

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript

Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Aldeyra Therapeutics (NASDAQ: ALDX) Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics first-quarter 2021 financial results conference call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. I would now like to hand the conference over to the company s chief financial officer, Joshua Reed. Please go ahead, sir. Chief Financial Officer Good morning, everyone. With me is Dr. Todd Brady, president, and chief executive officer of Aldeyra. This morning we issued a press release reporting our financial results for the quarter ended March 31, 2021.

Provention Bio, Inc (PRVB) Q4 2020 Earnings Call Transcript

Provention Bio, Inc (PRVB) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Provention Bio, Inc (NASDAQ: PRVB) Popular Searches Operator Good morning. My name is Alisa and I will be your conference operator today. At this time, I would like to welcome everyone to the Provention Bio Call. [Operator Instructions] I would now like to turn the call over to Mr. Robert Doody, Vice President of Investor Relations for Provention Bio. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.